Alves, Ana Paula Nunes Rodrigues; Fernandes, Jaqueline Cristina; Fenerich, Bruna Alves 
; Silva, Juan Luiz Coelho da; Scheucher, Priscila Santos ; Simões, Belinda Pinto ; Rego, Eduardo Magalhaes ; Ridley, Anne J. ; Machado Neto, João Agostinho ; Traina, Fabiola
Fonte: Cancer Letters. Unidades: FMRP, FM, ICB
Assuntos: LEUCEMIA, CÉLULAS SANGUINEAS, CITOTOXINAS, APOPTOSE, CÉLULAS CULTIVADAS DE TUMOR, ONCOGENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Ana Paula Nunes Rodrigues et al. IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells. Cancer Letters, v. 456, p. 59-68, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.canlet.2019.04.030. Acesso em: 03 maio 2024.APA
Alves, A. P. N. R., Fernandes, J. C., Fenerich, B. A., Silva, J. L. C. da, Scheucher, P. S., Simões, B. P., et al. (2019). IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells. Cancer Letters, 456, 59-68. doi:10.1016/j.canlet.2019.04.030NLM
Alves APNR, Fernandes JC, Fenerich BA, Silva JLC da, Scheucher PS, Simões BP, Rego EM, Ridley AJ, Machado Neto JA, Traina F. IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells [Internet]. Cancer Letters. 2019 ; 456 59-68.[citado 2024 maio 03 ] Available from: https://doi.org/10.1016/j.canlet.2019.04.030Vancouver
Alves APNR, Fernandes JC, Fenerich BA, Silva JLC da, Scheucher PS, Simões BP, Rego EM, Ridley AJ, Machado Neto JA, Traina F. IGF1R/IRS1 targeting has cytotoxic activity and inhibits PI3K/AKT/mTOR and MAPK signaling in acute lymphoblastic leukemia cells [Internet]. Cancer Letters. 2019 ; 456 59-68.[citado 2024 maio 03 ] Available from: https://doi.org/10.1016/j.canlet.2019.04.030
